We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Trial of Home Versus Clinic-based Screening for Sexually Transmitted Infections

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01184157
First Posted: August 18, 2010
Last Update Posted: August 18, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Washington University School of Medicine
  Purpose
This study randomizes women using long-acting reversible methods of contraception to home-based STD screening through the mail compared to screening available in a clinical setting. We hypothesize that women randomized to home-based screening will be more likely to complete screening.

Condition Intervention
Chlamydia Gonorrhea Behavioral: Home screening Behavioral: Clinic screening

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Screening
Official Title: Randomized Trial of Home Versus Clinic-based Screening for Sexually Transmitted Infections in Long-Acting Reversible Contraceptive Users

Resource links provided by NLM:


Further study details as provided by Washington University School of Medicine:

Primary Outcome Measures:
  • Number of tests received

Arms Assigned Interventions
Experimental: Home
Home-based STI screening using self-obtained vaginal swabs and postal return of samples.
Behavioral: Home screening
Active Comparator: Clinic
Receive STI screening in a clinical setting such as a private physician or clinic.
Behavioral: Clinic screening

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   14 Years to 45 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Criteria

Inclusion Criteria:

  • Participant in Contraceptive CHOICE cohort study
  • Using a long-acting reversible method of contraception
  • Completed baseline clinical survey in the Contraceptive CHOICE cohort study

Exclusion Criteria:

  • Living outside the United States at time of annual STI screening
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01184157


Locations
United States, Missouri
Washington University School of Medicine
St. Louis, Missouri, United States, 63108
Sponsors and Collaborators
Washington University School of Medicine
Investigators
Principal Investigator: Jeffrey Peipert, MD, PhD Washington University School of Medicine
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Jeffrey Peipert, MD PhD, Washington University School of Medicine
ClinicalTrials.gov Identifier: NCT01184157     History of Changes
Other Study ID Numbers: 07-0256
First Submitted: August 17, 2010
First Posted: August 18, 2010
Last Update Posted: August 18, 2010
Last Verified: August 2010

Additional relevant MeSH terms:
Sexually Transmitted Diseases
Gonorrhea
Infection
Virus Diseases
Genital Diseases, Male
Genital Diseases, Female
Neisseriaceae Infections
Gram-Negative Bacterial Infections
Bacterial Infections
Sexually Transmitted Diseases, Bacterial